Newborn Screening Market Worth $2.07 Billion by 2029

Newborn screening is a screening program for infants under which pre-symptomatic congenital conditions are detected so that treatment can be commenced as soon as possible to prevent or reduce the long-term consequences of the disease. These programs are usually run by the national or state governing bodies with the aim of screening all infants for a defined panel of disorders that are treatable.